Brabois Hospital
Vandœuvre-lès-Nancy, 54500, France
NCT Number: NCT03318588
Photoreceptor apoptosis is the basis for permanent visual loss in a number of retinal disorders including age-related macular degeneration (AMD) and retinal detachment (RD). Thus, despite tremendous advances in vitreoretinal surgery and management of rhegmatogenous RD leading to a primary reattachment rate over 95%, some patients show poor visual recovery because of photoreceptor apoptosis.
Physiologically, microglial cells (resident macrophages) are present only in the inner retina. The subretinal space, located between the retinal pigment epithelium (RPE) and the photoreceptor outer segments (POS), is devoid of all mononuclear phagocytes and form a zone of immune privilege. In AMD, several studies showed a strong association between subretinal mononuclear phagocytes infiltration and advanced forms of AMD. Experimental work in mice suggest that this infiltration plays an important role in the pathogenesis of this condition by producing inflammatory cytokines.
RD-induced photoreceptor apoptosis might result from similar mechanisms. The aim of this study is to determine the cytokine profile in vitreous samples from patients with RD and to compare it with those from control patients with macular hole.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vandœuvre-lès-Nancy, 54500, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pars plana vitrectomy
Time frame: up to one month after surgery
Central Hospital, Nancy, France
Other
Acronym: ICELAND
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04676256
Eye Diseases, Retinal Break
Paris, Île-de-France Region, France
View Trial DetailsNCT01767038
Eye Diseases, Retinal Detachment
Besançon, France
View Trial DetailsNCT07058337
Eye Diseases, Retinal Detachment
Cairo, Egypt
View Trial DetailsNCT03479736
Achilles Tendon, Acute Aortic Syndrome
Titusville, New Jersey, United States
View Trial Details